Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy.

Pluda, J M; Venzon, D J; Tosato, G; Lietzau, J; Wyvill, K; Nelson, D L; Jaffe, E S; Karp, J E; Broder, S; Yarchoan, R

Pluda, J M; Venzon, D J; Tosato, G; Lietzau, J; Wyvill, K; Nelson, D L; Jaffe, E S; Karp, J E; Broder, S; Yarchoan, R.

Affiliation

Pluda JM; Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

J Clin Oncol ; 11(6): 1099-107, 1993 Jun.

Article in En | MEDLINE | ID: mdl-8099121

Subject(s)

Didanosine/therapeutic use; HIV Infections/drug therapy; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin/etiology; Zidovudine/therapeutic use; CD4-Positive T-Lymphocytes; Didanosine/adverse effects; HIV Infections/complications; HIV Infections/immunology; Humans; Interleukin-6/blood; Leukocyte Count; Lymphoma, AIDS-Related/immunology; Risk Factors; Zidovudine/adverse effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Zidovudine / HIV Infections / Lymphoma, AIDS-Related / Didanosine Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Clin Oncol Year: 1993 Type: Article

Search on Google

XML

PubMed Links